These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

575 related items for PubMed ID: 23127774

  • 1. Multicentre treatment planning study of MRI-guided brachytherapy for cervical cancer: comparison between tandem-ovoid applicator users.
    Nomden CN, de Leeuw AA, Van Limbergen E, de Brabandere M, Nulens A, Nout RA, Laman M, Ketelaars M, Lutgens L, Reniers B, Jürgenliemk-Schulz IM.
    Radiother Oncol; 2013 Apr; 107(1):82-7. PubMed ID: 23127774
    [Abstract] [Full Text] [Related]

  • 2. MRI-guided treatment-planning optimisation in intracavitary or combined intracavitary/interstitial PDR brachytherapy using tandem ovoid applicators in locally advanced cervical cancer.
    Jürgenliemk-Schulz IM, Tersteeg RJ, Roesink JM, Bijmolt S, Nomden CN, Moerland MA, de Leeuw AA.
    Radiother Oncol; 2009 Nov; 93(2):322-30. PubMed ID: 19748695
    [Abstract] [Full Text] [Related]

  • 3. Feasibility of applying a single treatment plan for both fractions in PDR image guided brachytherapy in cervix cancer.
    Mohamed S, Nielsen SK, Fokdal LU, Pedersen EM, Lindegaard JC, Tanderup K.
    Radiother Oncol; 2013 Apr; 107(1):32-8. PubMed ID: 23333020
    [Abstract] [Full Text] [Related]

  • 4. Clinical outcome and dosimetric parameters of chemo-radiation including MRI guided adaptive brachytherapy with tandem-ovoid applicators for cervical cancer patients: a single institution experience.
    Nomden CN, de Leeuw AA, Roesink JM, Tersteeg RJ, Moerland MA, Witteveen PO, Schreuder HW, van Dorst EB, Jürgenliemk-Schulz IM.
    Radiother Oncol; 2013 Apr; 107(1):69-74. PubMed ID: 23639580
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A dose planning study on applicator guided stereotactic IMRT boost in combination with 3D MRI based brachytherapy in locally advanced cervical cancer.
    Assenholt MS, Petersen JB, Nielsen SK, Lindegaard JC, Tanderup K.
    Acta Oncol; 2008 Apr; 47(7):1337-43. PubMed ID: 18663651
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical use of the Utrecht applicator for combined intracavitary/interstitial brachytherapy treatment in locally advanced cervical cancer.
    Nomden CN, de Leeuw AA, Moerland MA, Roesink JM, Tersteeg RJ, Jürgenliemk-Schulz IM.
    Int J Radiat Oncol Biol Phys; 2012 Mar 15; 82(4):1424-30. PubMed ID: 21669505
    [Abstract] [Full Text] [Related]

  • 10. Adaptive image guided brachytherapy for cervical cancer: a combined MRI-/CT-planning technique with MRI only at first fraction.
    Nesvacil N, Pötter R, Sturdza A, Hegazy N, Federico M, Kirisits C.
    Radiother Oncol; 2013 Apr 15; 107(1):75-81. PubMed ID: 23068712
    [Abstract] [Full Text] [Related]

  • 11. Practically achievable maximum high-risk clinical target volume doses in MRI-guided intracavitary brachytherapy for cervical cancer: a planning study.
    Menon G, Huang F, Sloboda R, Pearcey R, Ghosh S.
    Brachytherapy; 2014 Apr 15; 13(6):572-8. PubMed ID: 25085455
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Dosimetric impact of interobserver variability in MRI-based delineation for cervical cancer brachytherapy.
    Hellebust TP, Tanderup K, Lervåg C, Fidarova E, Berger D, Malinen E, Pötter R, Petrič P.
    Radiother Oncol; 2013 Apr 15; 107(1):13-9. PubMed ID: 23462706
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Dose escalation in brachytherapy for cervical cancer: impact on (or increased need for) MRI-guided plan optimisation.
    Paton AM, Chalmers KE, Coomber H, Cameron AL.
    Br J Radiol; 2012 Dec 15; 85(1020):e1249-55. PubMed ID: 23175490
    [Abstract] [Full Text] [Related]

  • 16. Intensity modulated proton beam radiation for brachytherapy in patients with cervical carcinoma.
    Clivio A, Kluge A, Cozzi L, Köhler C, Neumann O, Vanetti E, Wlodarczyk W, Marnitz S.
    Int J Radiat Oncol Biol Phys; 2013 Dec 01; 87(5):897-903. PubMed ID: 24119834
    [Abstract] [Full Text] [Related]

  • 17. From point A to the sculpted pear: MR image guidance significantly improves tumour dose and sparing of organs at risk in brachytherapy of cervical cancer.
    Tanderup K, Nielsen SK, Nyvang GB, Pedersen EM, Røhl L, Aagaard T, Fokdal L, Lindegaard JC.
    Radiother Oncol; 2010 Feb 01; 94(2):173-80. PubMed ID: 20138380
    [Abstract] [Full Text] [Related]

  • 18. Determining DVH parameters for combined external beam and brachytherapy treatment: 3D biological dose adding for patients with cervical cancer.
    Van de Kamer JB, De Leeuw AA, Moerland MA, Jürgenliemk-Schulz IM.
    Radiother Oncol; 2010 Feb 01; 94(2):248-53. PubMed ID: 20080309
    [Abstract] [Full Text] [Related]

  • 19. Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer.
    Kirisits C, Pötter R, Lang S, Dimopoulos J, Wachter-Gerstner N, Georg D.
    Int J Radiat Oncol Biol Phys; 2005 Jul 01; 62(3):901-11. PubMed ID: 15936576
    [Abstract] [Full Text] [Related]

  • 20. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
    Ribeiro I, Janssen H, De Brabandere M, Nulens A, De Bal D, Vergote I, Van Limbergen E.
    Radiother Oncol; 2016 Sep 01; 120(3):447-454. PubMed ID: 27157510
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.